Supernus Pharmaceuticals gets grant for patent granted for compound of formula ii for CNS disorders

2d ago, source: Pharmaceutical Technology

Discover Supernus Pharmaceuticals Inc's groundbreaking patent for a versatile compound aimed at treating central nervous system disorders. Learn about the innovative formula, derivatives, and ...

Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease

on MSN ago, source:

Supernus Pharmaceuticals receives FDA Complete Response Letter for SPN-830, an investigational apomorphine infusion device ...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

4d ago, source:

New York, New York-- (Newsfile Corp. - April 22, 2024) - Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN).

Analysts Are Bullish on Top Healthcare Stocks: BioCryst (BCRX), Ironwood Pharma (IRWD)

4d ago, source:

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioCryst (BCRX – Research Report), ...

Rx Rundown: Vertex Pharmaceuticals, Bristol Myers Squibb, Novartis and more

14d ago, source: MM&M

Vertex Pharmaceuticals announced its biggest M&A play yet, acquiring Alpine Immune Sciences for $4.9 billion. MM+M is proud ...

No New Safety Signals Seen With Migraine Prevention Drug

9d ago, source: MedPage Today on MSN

DENVER -- No new safety signals emerged with daily atogepant (Qulipta) for migraine prevention, an interim analysis of a long ...

Severity of Resistant Depression Predicts Ketamine vs ECT Response

1d ago, source: Medscape

The severity of TRD appeared to predict response to IV ketamine vs ECT. However, experts said more research is needed before ...

Should You Invest in Coherus Biosciences Inc (CHRS) Now?

22h ago, source: newsheater

In conclusion, Coherus Biosciences Inc (CHRS) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important ...

Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session

on MSN ago, source:

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday. Shares of Marinus ...

Why Is Marinus Pharmaceuticals (MRNS) Stock Down 79% Today?

on MSN ago, source:

Marinus Pharmaceuticals stock is falling on Monday with heavy trading of MRNS shares after posting an update on a Phase 3 ...